Schroder Investment Management Group
JAZZ icon

Schroder Investment Management Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Schroder Investment Management Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.74M Sell
25,077
-15,290
-38% -$2.67M ﹤0.01% 791
2025
Q4 		$6.9M Buy
+40,367
New +$6.19M 0.01% 704
2025
Q3 		– Sell
-17,816
Closed -$1.89M – 1224
2025
Q2 		$1.89M Buy
17,816
+8,444
+90% +$917K ﹤0.01% 918
2025
Q1 		$1.15M Buy
+9,372
New +$1.22M ﹤0.01% 973
2024
Q4 		– Sell
-50,555
Closed -$5.61M – 1222
2024
Q3 		$5.61M Buy
50,555
+19,412
+62% +$2.13M 0.01% 767
2024
Q2 		$3.32M Sell
31,143
-27,114
-47% -$2.98M ﹤0.01% 858
2024
Q1 		$7.02M Buy
58,257
+10,698
+22% +$1.31M 0.01% 722
2023
Q4 		$5.85M Buy
47,559
+43,044
+953% +$5.37M 0.01% 735
2023
Q3 		$584K Sell
4,515
-3,792
-46% -$505K ﹤0.01% 1072
2023
Q2 		$1.03M Sell
8,307
-116,318
-93% -$15.7M ﹤0.01% 1048
2023
Q1 		$18.2M Sell
124,625
-24,995
-17% -$3.7M 0.03% 494
2022
Q4 		$23.8M Buy
149,620
+13,596
+10% +$1.99M 0.04% 417
2022
Q3 		$18.1M Sell
136,024
-6,242
-4% -$949K 0.03% 466
2022
Q2 		$22.2M Sell
142,266
-42,941
-23% -$6.61M 0.03% 437
2022
Q1 		$29.2M Buy
185,207
+38,921
+27% +$5.65M 0.04% 405
2021
Q4 		$18.6M Sell
146,286
-22,105
-13% -$2.91M 0.02% 480
2021
Q3 		$21.9M Buy
168,391
+33,752
+25% +$5.1M 0.03% 465
2021
Q2 		$23.9M Buy
134,639
+23,557
+21% +$4.08M 0.03% 477
2021
Q1 		$18.3M Buy
111,082
+21,223
+24% +$3.49M 0.02% 529
2020
Q4 		$14.8M Sell
89,859
-14,850
-14% -$2.21M 0.02% 554
2020
Q3 		$15M Sell
104,709
-26,289
-20% -$3.26M 0.02% 494
2020
Q2 		$14.5M Buy
130,998
+2,047
+2% +$226K 0.03% 486
2020
Q1 		$13.6M Sell
128,951
-61,548
-32% -$7.96M 0.03% 458
2019
Q4 		$28.4M Buy
190,499
+24,131
+15% +$3.28M 0.05% 415
2019
Q3 		$21.2M Buy
166,368
+28,468
+21% +$3.82M 0.04% 445
2019
Q2 		$19.7M Buy
137,900
+110,047
+395% +$14.8M 0.04% 452
2019
Q1 		$3.98M Hold
27,853
– – 0.01% 729
2018
Q4 		$3.45K Sell
27,853
-750
-3% -$111K 0.01% 729
2018
Q3 		$4.81M Sell
28,603
-115,950
-80% -$19.9M 0.01% 707
2018
Q2 		$25.1M Sell
144,553
-76,747
-35% -$12.5M 0.04% 409
2018
Q1 		$33.4M Sell
221,300
-32,600
-13% -$4.78M 0.06% 348
2017
Q4 		$34.2M Sell
253,900
-101,000
-28% -$14M 0.06% 367
2017
Q3 		$52.6M Buy
+354,900
New +$53.7M 0.09% 275
2014
Q2 		– Sell
-16,100
Closed -$2.23M – 1413
2014
Q1 		$2.23M Sell
16,100
-22,900
-59% -$3.45M ﹤0.01% 890
2013
Q4 		$4.94M Buy
39,000
+5,400
+16% +$559K 0.01% 800
2013
Q3 		$3.09M Buy
33,600
+9,400
+39% +$758K 0.01% 836
2013
Q2 		$1.66M Buy
+24,200
New +$1.48M ﹤0.01% 926

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Schroder Investment Management Group's JAZZ Position: Q1 2026 in Review

Schroder Investment Management Group reduced its Jazz Pharmaceuticals (JAZZ) stake by 38% in Q1 2026, selling an estimated $2.67M and leaving 25,077 shares worth $4.74M. The position accounts for ﹤0.01% of the portfolio, ranked #791.

Schroder Investment Management Group first reported a position in JAZZ in Q2 2013 and has held it in 37 quarters since. The position peaked at $52.6M in Q3 2017. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Schroder Investment Management Group held 25,077 shares of Jazz Pharmaceuticals worth $4.74M as of Q1 2026.
  • Schroder Investment Management Group sold 15,290 Jazz Pharmaceuticals shares in Q1 2026, an estimated $2.67M.
  • Jazz Pharmaceuticals made up ﹤0.01% of Schroder Investment Management Group's portfolio in Q1 2026, its #791 holding.
  • Schroder Investment Management Group first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 37 quarters since.
  • Schroder Investment Management Group's Jazz Pharmaceuticals position peaked at $52.6M in Q3 2017.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Schroder Investment Management Group's 13F filing for Q1 2026, filed 14 May 2026.